iRhythm Holdings, Inc. financials

IRTC CIK 0001388658

Source: EDGAR filings · Built 2026-06-02T03:19:38Z

Key metrics by reporting period

Up to six most-recent periods side-by-side. Rows are the curated key lines — revenue, margins, cash, debt, equity, cash-flow totals, plus the derived and valuation metrics we compute on top. For every tag a filer reported in one period, use the single-filing drilldown below.

Derived Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Free Cash Flow 34.52M -30.55M -90.53M -52.84M -65.82M -27.31M
EBITDA -36.71M -94.81M -108.86M -100.38M -90.14M -36.77M
Working Capital 550.88M 534.90M 123.44M 199.68M 217.67M 312.16M
Net Debt 495.17M 317.31M 93.65M 52.21M -9.85M 33.84M
Gross Margin 70.57% 68.86% 67.35% 68.54% 66.16% 73.50%
Operating Margin -7.68% -19.52% -25.40% -27.69% -30.96% -16.47%
Net Margin -5.96% -19.14% -25.05% -28.27% -31.40% -16.53%
Return on Equity (ROE) -29.17% -124.62% -58.74% -48.44% -36.26% -12.83%
Return on Assets (ROA) -4.37% -12.16% -28.49% -25.91% -21.89% -8.56%
Current Ratio 4.63× 5.82× 2.15× 3.24× 3.48× 5.75×
Debt-to-Equity 4.79× 8.11× 0.62× 0.55× 0.42× 0.36×
Effective Tax Rate -2.19% -0.50% -0.61% -0.23% -0.36% -0.53%
Cash Conversion Ratio -1.82× -0.03× 0.41× 0.20× 0.37× 0.31×
Accruals Ratio -0.12× -0.13× -0.17× -0.21× -0.14× -0.06×
SBC % of Revenue 11.82% 12.84% 15.67% 14.05% 16.89% 15.66%
CapEx Coverage 1.74× 0.10× -1.24× -0.77× -1.35× -1.02×
Free Cash Flow Per Share $1.08 $-0.98 $-2.97 $-1.77 $-2.24 $-0.98

Valuation Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
P/FCF 164.51×
FCF Yield 0.61%
P/S 7.67× 4.78× 6.73× 6.88× 10.75× 25.96×
P/B 37.52× 31.14× 15.77× 11.79× 12.42× 20.15×

Income Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Revenue from Contract with Customer, Excluding Assessed Tax 747.14M 591.84M 492.68M 410.92M 322.82M 265.17M
Cost of Revenue 219.89M 184.31M 160.88M 129.29M 109.26M 70.28M
Gross Profit 527.25M 407.53M 331.81M 281.63M 213.57M 194.89M
Research and Development Expense 60.24M 46.61M 38.67M 41.33M
Selling, General and Administrative Expense 492.55M 418.56M 385.64M 322.20M 274.84M 197.23M
Operating Expenses 584.66M 523.04M 456.97M 395.42M 313.51M 238.56M
Operating Income (Loss) -57.41M -115.50M -125.16M -113.78M -99.94M -43.67M
Income Tax Expense (Benefit) 953.00K 565.00K 750.00K 269.00K 367.00K 229.00K
Net Income (Loss) Attributable to Parent -44.55M -113.29M -123.41M -116.16M -101.36M -43.83M
Earnings Per Share, Basic $-1.39 $-3.63 $-4.04 $-3.88 $-3.46 $-1.58
Weighted Average Number of Shares Outstanding, Basic 32.00M 31.20M 30.53M 29.92M 29.33M 27.75M
Earnings Per Share, Diluted $-1.39 $-3.63 $-4.04 $-3.88 $-3.46 $-1.58
Weighted Average Number of Shares Outstanding, Diluted 32.00M 31.20M 30.53M 29.92M 29.33M 27.75M

Balance Sheet

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Cash and Cash Equivalents, at Carrying Value 236.01M 419.60M 36.17M 78.83M 127.56M 88.63M
Assets, Current 702.76M 645.82M 230.81M 288.77M 305.52M 377.82M
Assets 1.02B 931.45M 433.14M 448.22M 462.97M 511.74M
Long-term Debt 9.69M 21.34M
Liabilities, Current 151.89M 110.92M 107.37M 89.10M 87.85M 65.67M
Long-term Debt, Excluding Current Maturities 34.95M 34.94M 9.69M 21.34M
Liabilities 867.30M 840.54M 223.05M 208.41M 183.45M 170.13M
Stockholders' Equity Attributable to Parent 152.75M 90.91M 210.10M 239.81M 279.51M 341.61M
Common Stock, Shares, Outstanding 32.30M 31.39M 30.95M 30.19M 29.49M 29.02M

Cash Flow Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Net Cash Provided by (Used in) Operating Activities 80.86M 3.39M -50.10M -23.01M -37.75M -13.76M
Payments to Acquire Property, Plant, and Equipment 46.34M 33.94M 40.42M 29.83M 28.07M 13.55M
Net Cash Provided by (Used in) Investing Activities -277.06M -122.98M -1.21M -52.43M 105.26M -132.39M
Payments for Repurchase of Common Stock 0 25.00M 0 0
Net Cash Provided by (Used in) Financing Activities 12.61M 511.38M 8.82M 26.72M -28.58M 214.32M

Raw XBRL tagging for a single filing

Every us-gaap and custom concept the filer tagged for one fiscal period, grouped by statement. Start here when a number in the trend table above surprises you and you want to see the exact tag behind it. Derived and valuation rows are omitted here because they already appear in the trend table.

Most recent filing shown by default.

Compare filings side-by-side

Diff any two filings with deltas and added / removed tags.

Immaterial rows are USD line items under 1% of the period's revenue — the noise floor below which a single tag rarely moves the investment thesis. Revenue is read from the filer's top-line concept (Revenues / RevenueFromContractWithCustomerExcludingAssessedTax, with a fallback chain). Non-USD rows, rows without a numeric value, and every row on a filing with no identifiable revenue anchor stay visible. Flip the switch off to see every tag the filer reported for the period.

Loading filing details…

Methodology

All facts on this page come straight from SEC EDGAR XBRL company-facts filings (IRTC CIK 0001388658), grouped by financial statement using FASB's base us-gaap presentation taxonomy. Filers may re-parent concepts onto different statements in their own extension taxonomy, so a handful of rows can show up under a different statement than on the actual 10-K / 10-Q; custom concepts and any we couldn't map fall into Other. Hover a cell to see the fully-qualified concept name and the filer's description.

For the full methodology — statement grouping, the Other bucket, derived metrics, and fact tooltips — see the methodology reference for the statement grouping, the "Other" bucket, derived metrics, and fact tooltips.

Related tickers

BEAM

Beam Therapeutics Inc.

IDYA

IDEAYA Biosciences, Inc.

RXO

RXO, INC.